Related Experiment Video
Updated: Jul 10, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference
1Department of Medical Genetics, Medical University Vienna, Vienna, Austria.
Abstract:
Heterozygous germline mutations in one of the mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2 cause hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome, a dominantly inherited cancer susceptibility syndrome. Recent reports provide evidence for a novel recessively inherited cancer syndrome with constitutive MMR deficiency due to biallelic germline mutations in one of the MMR genes. MMR-deficiency (MMR-D) syndrome is characterized by childhood brain tumors, hematological and/or gastrointestinal malignancies, and signs of neurofibromatosis type 1 (NF1). We established an RNA-based mutation detection assay for the four MMR genes, since 1) a number of splicing defects may escape detection by the analysis of genomic DNA, and 2) DNA-based mutation detection in the PMS2 gene is severely hampered by the presence of multiple highly similar pseudogenes, including PMS2CL. Using this assay, which is based on direct cDNA sequencing of RT-PCR products, we investigated two families with children suspected to suffer from MMR-D syndrome. We identified a homozygous complex MSH6 splicing alteration in the index patients of the first family and a novel homozygous PMS2 mutation (c.182delA) in the index patient of the second family. Furthermore, we demonstrate, by the analysis of a PMS2/PMS2CL "hybrid" allele carrier, that RNA-based PMS2 testing effectively avoids the caveats of genomic DNA amplification approaches; i.e., pseudogene coamplification as well as allelic dropout, and will, thus, allow more sensitive mutation analysis in MMR deficiency and in HNPCC patients with PMS2 defects.
Insights
A novel RNA-based assay detects genetic mutations in mismatch repair (MMR) genes, crucial for diagnosing rare MMR-deficiency (MMR-D) syndrome and hereditary nonpolyposis colorectal cancer (HNPCC). This method improves accuracy for PMS2 gene mutations.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Lynch syndrome, caused by heterozygous mismatch repair (MMR) gene mutations, is a dominant cancer susceptibility syndrome.
- A novel, recessively inherited MMR-deficiency (MMR-D) syndrome presents with childhood brain tumors and malignancies, linked to biallelic MMR gene mutations.
- Accurate genetic testing for MMR genes is essential for diagnosing these conditions.
Purpose of the Study:
- To develop and validate an RNA-based mutation detection assay for MMR genes (MLH1, MSH2, MSH6, PMS2).
- To address limitations of DNA-based testing, particularly for PMS2 due to pseudogenes and potential splicing defects.
- To investigate families with suspected MMR-D syndrome.
Main Methods:
- Established an RNA-based mutation detection assay using direct cDNA sequencing of RT-PCR products for four key MMR genes.
- Applied the assay to two families with children exhibiting symptoms suggestive of MMR-D syndrome.
- Analyzed a carrier of a PMS2/PMS2CL "hybrid" allele to assess assay performance.
Main Results:
- Identified a homozygous complex MSH6 splicing alteration in the first family's index patients.
- Discovered a novel homozygous PMS2 mutation (c.182delA) in the second family's index patient.
- Demonstrated that the RNA-based assay effectively avoids pseudogene coamplification and allelic dropout, enhancing PMS2 mutation analysis.
Conclusions:
- The RNA-based assay provides a sensitive and accurate method for detecting MMR gene mutations, including complex splicing alterations and PMS2 defects.
- This assay improves diagnostic capabilities for both MMR-deficiency (MMR-D) syndrome and Lynch syndrome (HNPCC), especially when PMS2 pseudogenes complicate genomic DNA analysis.
- The developed assay offers a significant advancement in identifying genetic causes of hereditary cancer syndromes.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Mismatch Repair
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
RNA Splicing
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...